NL-OMON24479招募中不适用
Optimising adalimumab treatment in psoriasis with concomitant methotrexate.
Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Have a diagnosis of moderate to severe plaque psoriasis (PASI≥8 at time of screening);
- •-Is a candidate for the treatment with biologic drugs according to the pertaining guidelines;
排除标准
- •-History of significant MTX or adalimumab toxicity, intolerability or contraindication
- •-Prior treatment with adalimumab
研究者
相似试验
进行中（未招募）
1 期
Optimising adalimumab treatment in psoriasis with concomitant methotrexate.EUCTR2013-004918-18-NLAcademic Medical Center100
已完成
4 期
Optimising adalimumab treatment in psoriasis with concomitant methotrexate.NL-OMON45239Academisch Medisch Centrum100
进行中（未招募）
1 期
Optimising adalimumab treatment in psoriasis with concomitant methotrexate.psoriasisMedDRA version: 20.0Level: PTClassification code 10037153Term: PsoriasisSystem Organ Class: 10040785 - Skin and subcutaneous tissue disordersEUCTR2013-004918-18-BEGhent University Hospital100
进行中（未招募）
不适用
Adalimumab for psoriasis patients who are non-responders to etanercept: An open-label study - adalimumab for psoriasis patients who are non-responders to etanerceptpsoriasisMedDRA version: 8.1Level: LLTClassification code 10037153Term: PsoriasisEUCTR2006-004971-37-GBKing's College London
撤回
4 期
Optimizing the treatment of psoriasis with methotrexate; after 40 years the first dose-finding study.psoriasis10014982NL-OMON37246Academisch Medisch Centrum80